India Lipid Market Size & Outlook, 2022-2030
India lipid market, 2018-2030 (US$M)
Related Markets
India lipid market highlights
- The India lipid market generated a revenue of USD 513.8 million in 2022 and is expected to reach USD 901.9 million by 2030.
- The India market is expected to grow at a CAGR of 7.3% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 513.8 million |
| Market revenue in 2030 | USD 901.9 million |
| Growth rate | 7.3% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, India accounted for 5.5% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China lipid market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 989.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the India lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
India is witnessing rising instances of atherosclerotic cardiovascular disease (ASCVD). The risk of Coronary artery disease (CAD) is rapidly increasing among people younger than 40 years. According to reports, around 10%-25% of myocardial infarctions (MI) in India occur in people younger than 40 years.
Lipid particles significantly contribute to the treatment of cardiovascular disease and influence inflammatory processes. Hence, omega 3 is heavily consumed in the formulation of drugs for the treatment of heart diseases. The increasing risk of heart disease is anticipated to propel the utilization of lipids in pharmaceutical and healthcare industries in India over the projected years.
Reasons to subscribe to India lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India lipid market , including forecasts for subscribers. This country databook contains high-level insights into India lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India lipid market size, by phase, 2018-2030 (US$M)
India Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
